 Virginia Ferguson
Concepts (445)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 12 | 2022 | 289 | 3.230 |
Why?
| | Bone and Bones | 12 | 2020 | 282 | 2.590 |
Why?
| | Space Flight | 18 | 2021 | 127 | 2.290 |
Why?
| | Weightlessness | 11 | 2021 | 79 | 2.100 |
Why?
| | Growth Plate | 3 | 2022 | 33 | 1.600 |
Why?
| | Osteocytes | 6 | 2022 | 22 | 1.490 |
Why?
| | Hindlimb Suspension | 8 | 2013 | 24 | 1.340 |
Why?
| | Bone Remodeling | 6 | 2021 | 65 | 1.260 |
Why?
| | Biomechanical Phenomena | 18 | 2020 | 676 | 1.200 |
Why?
| | Finite Element Analysis | 10 | 2019 | 66 | 1.120 |
Why?
| | Collagen | 7 | 2020 | 416 | 1.100 |
Why?
| | Muscular Atrophy | 5 | 2020 | 78 | 1.070 |
Why?
| | Cortical Bone | 4 | 2020 | 18 | 1.070 |
Why?
| | Bone Diseases, Metabolic | 4 | 2021 | 53 | 1.060 |
Why?
| | Calcification, Physiologic | 9 | 2020 | 34 | 1.050 |
Why?
| | Osteoarthritis | 3 | 2016 | 172 | 1.020 |
Why?
| | Cartilage | 4 | 2022 | 182 | 0.970 |
Why?
| | Animals | 67 | 2023 | 31884 | 0.920 |
Why?
| | Splenic Artery | 4 | 2016 | 13 | 0.920 |
Why?
| | Glycosaminoglycans | 5 | 2021 | 79 | 0.900 |
Why?
| | Muscle, Skeletal | 11 | 2020 | 1477 | 0.890 |
Why?
| | Mechanical Phenomena | 4 | 2018 | 80 | 0.880 |
Why?
| | Extracellular Matrix | 5 | 2022 | 436 | 0.870 |
Why?
| | Aging | 6 | 2019 | 1624 | 0.840 |
Why?
| | Umbilical Arteries | 2 | 2013 | 41 | 0.830 |
Why?
| | Mice, Inbred C57BL | 27 | 2021 | 4718 | 0.820 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2019 | 486 | 0.820 |
Why?
| | Tibia | 9 | 2022 | 169 | 0.790 |
Why?
| | Osteoporosis | 3 | 2020 | 225 | 0.770 |
Why?
| | Hydrogels | 8 | 2022 | 575 | 0.760 |
Why?
| | Elasticity | 8 | 2017 | 190 | 0.750 |
Why?
| | Femur | 11 | 2021 | 193 | 0.710 |
Why?
| | Bone Density | 14 | 2022 | 432 | 0.700 |
Why?
| | Sepharose | 2 | 2017 | 31 | 0.690 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 466 | 0.690 |
Why?
| | Hindlimb | 4 | 2021 | 130 | 0.680 |
Why?
| | Fractures, Bone | 3 | 2021 | 373 | 0.640 |
Why?
| | Physical Conditioning, Animal | 3 | 2010 | 196 | 0.630 |
Why?
| | Polyethylene Glycols | 6 | 2022 | 561 | 0.620 |
Why?
| | Vascular Stiffness | 2 | 2013 | 414 | 0.620 |
Why?
| | Tissue Engineering | 7 | 2022 | 366 | 0.610 |
Why?
| | Mice | 38 | 2023 | 14934 | 0.610 |
Why?
| | Tissue Scaffolds | 3 | 2021 | 179 | 0.600 |
Why?
| | Models, Theoretical | 2 | 2017 | 517 | 0.550 |
Why?
| | Muscle Strength | 3 | 2020 | 271 | 0.530 |
Why?
| | Macrophage Colony-Stimulating Factor | 3 | 2011 | 17 | 0.520 |
Why?
| | Cancellous Bone | 4 | 2020 | 20 | 0.510 |
Why?
| | Cervix Uteri | 1 | 2015 | 44 | 0.490 |
Why?
| | Water | 2 | 2016 | 410 | 0.490 |
Why?
| | Carotid Arteries | 2 | 2013 | 183 | 0.470 |
Why?
| | Chondrocytes | 1 | 2016 | 199 | 0.470 |
Why?
| | Stress, Mechanical | 7 | 2022 | 449 | 0.460 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2013 | 286 | 0.450 |
Why?
| | Software | 1 | 2018 | 538 | 0.450 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 39 | 0.450 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 699 | 0.450 |
Why?
| | Muscle Fatigue | 2 | 2013 | 94 | 0.430 |
Why?
| | Intervertebral Disc | 1 | 2013 | 37 | 0.430 |
Why?
| | Adaptation, Biological | 1 | 2013 | 54 | 0.430 |
Why?
| | Tooth Wear | 1 | 2012 | 18 | 0.410 |
Why?
| | Neurophysiology | 1 | 2012 | 14 | 0.410 |
Why?
| | Dental Enamel | 1 | 2012 | 64 | 0.400 |
Why?
| | Anisotropy | 3 | 2016 | 62 | 0.400 |
Why?
| | Lemur | 1 | 2012 | 51 | 0.400 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 212 | 0.390 |
Why?
| | Horses | 2 | 2009 | 96 | 0.390 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 261 | 0.370 |
Why?
| | Haversian System | 1 | 2010 | 2 | 0.370 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 165 | 0.370 |
Why?
| | Swine | 7 | 2019 | 705 | 0.370 |
Why?
| | Cartilage Diseases | 2 | 2019 | 40 | 0.370 |
Why?
| | Porosity | 3 | 2020 | 89 | 0.340 |
Why?
| | Gene Expression Regulation | 6 | 2019 | 2330 | 0.340 |
Why?
| | Bone Development | 4 | 2004 | 48 | 0.340 |
Why?
| | Electric Stimulation | 2 | 2013 | 261 | 0.330 |
Why?
| | Spleen | 5 | 2017 | 486 | 0.330 |
Why?
| | Umbilical Cord | 1 | 2009 | 80 | 0.320 |
Why?
| | Metacarpal Bones | 1 | 2008 | 12 | 0.320 |
Why?
| | Female | 38 | 2023 | 59717 | 0.310 |
Why?
| | Regenerative Medicine | 2 | 2019 | 41 | 0.310 |
Why?
| | Male | 29 | 2021 | 55811 | 0.300 |
Why?
| | Osteoblasts | 4 | 2020 | 106 | 0.290 |
Why?
| | X-Ray Microtomography | 3 | 2019 | 74 | 0.290 |
Why?
| | Exercise Test | 2 | 2013 | 545 | 0.290 |
Why?
| | Osteogenesis | 2 | 2019 | 183 | 0.290 |
Why?
| | Bone Diseases | 2 | 2018 | 57 | 0.290 |
Why?
| | Thymus Gland | 4 | 2013 | 296 | 0.280 |
Why?
| | Compressive Strength | 3 | 2019 | 70 | 0.280 |
Why?
| | Recovery of Function | 1 | 2010 | 577 | 0.270 |
Why?
| | Cattle | 3 | 2022 | 925 | 0.270 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 356 | 0.270 |
Why?
| | Tensile Strength | 3 | 2015 | 97 | 0.260 |
Why?
| | Phantoms, Imaging | 2 | 2018 | 137 | 0.260 |
Why?
| | Elastic Modulus | 3 | 2016 | 116 | 0.260 |
Why?
| | Arteries | 3 | 2018 | 249 | 0.260 |
Why?
| | Microscopy, Confocal | 2 | 2018 | 305 | 0.250 |
Why?
| | Models, Biological | 4 | 2016 | 1638 | 0.250 |
Why?
| | Materials Testing | 4 | 2016 | 345 | 0.250 |
Why?
| | Pregnancy | 6 | 2015 | 5525 | 0.250 |
Why?
| | Elasticity Imaging Techniques | 2 | 2016 | 44 | 0.250 |
Why?
| | Rabbits | 3 | 2022 | 750 | 0.240 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 538 | 0.240 |
Why?
| | Printing, Three-Dimensional | 3 | 2022 | 61 | 0.240 |
Why?
| | Algorithms | 3 | 2018 | 1488 | 0.230 |
Why?
| | Neurons | 1 | 2012 | 1285 | 0.230 |
Why?
| | Body Composition | 2 | 2021 | 586 | 0.230 |
Why?
| | Physical Examination | 1 | 2005 | 221 | 0.220 |
Why?
| | Femur Head | 1 | 2003 | 33 | 0.220 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 180 | 0.220 |
Why?
| | Computer Simulation | 3 | 2016 | 879 | 0.220 |
Why?
| | Temperature | 2 | 2018 | 578 | 0.220 |
Why?
| | Osteoclasts | 2 | 2020 | 34 | 0.220 |
Why?
| | Elastin | 2 | 2013 | 78 | 0.210 |
Why?
| | Pelvic Floor | 1 | 2023 | 24 | 0.210 |
Why?
| | Disease Models, Animal | 8 | 2019 | 3547 | 0.210 |
Why?
| | Bone Resorption | 3 | 2015 | 73 | 0.210 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 40 | 0.210 |
Why?
| | Sheep | 3 | 2013 | 764 | 0.200 |
Why?
| | Stereolithography | 2 | 2021 | 8 | 0.200 |
Why?
| | Esters | 1 | 2022 | 61 | 0.200 |
Why?
| | Dinoprostone | 1 | 2022 | 185 | 0.200 |
Why?
| | Humans | 32 | 2022 | 115219 | 0.200 |
Why?
| | Pressure | 4 | 2015 | 219 | 0.190 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 158 | 0.190 |
Why?
| | Biomimetics | 1 | 2021 | 36 | 0.190 |
Why?
| | Exercise Therapy | 1 | 2005 | 351 | 0.190 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 57 | 0.190 |
Why?
| | Calcinosis | 1 | 2003 | 242 | 0.180 |
Why?
| | Myosin Heavy Chains | 2 | 2013 | 178 | 0.180 |
Why?
| | Second Harmonic Generation Microscopy | 1 | 2020 | 3 | 0.180 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 309 | 0.180 |
Why?
| | Multiple Myeloma | 1 | 2002 | 92 | 0.180 |
Why?
| | Nursing Care | 1 | 2001 | 31 | 0.180 |
Why?
| | Bone Matrix | 2 | 2019 | 6 | 0.180 |
Why?
| | United States National Aeronautics and Space Administration | 1 | 2020 | 4 | 0.180 |
Why?
| | Spectrum Analysis, Raman | 1 | 2020 | 41 | 0.180 |
Why?
| | Hardness Tests | 2 | 2010 | 2 | 0.180 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 192 | 0.180 |
Why?
| | Weightlessness Simulation | 1 | 2020 | 13 | 0.180 |
Why?
| | Myostatin | 1 | 2020 | 26 | 0.180 |
Why?
| | Aerospace Medicine | 1 | 2020 | 19 | 0.170 |
Why?
| | Salter-Harris Fractures | 1 | 2019 | 11 | 0.170 |
Why?
| | Organ Size | 5 | 2013 | 444 | 0.170 |
Why?
| | Liver | 3 | 2017 | 1688 | 0.170 |
Why?
| | Oxidative Stress | 4 | 2018 | 1086 | 0.170 |
Why?
| | Fracture Healing | 1 | 2020 | 76 | 0.170 |
Why?
| | Disease Progression | 2 | 2016 | 2390 | 0.170 |
Why?
| | Scattering, Small Angle | 1 | 2019 | 20 | 0.170 |
Why?
| | Ligation | 2 | 2016 | 76 | 0.160 |
Why?
| | X-Ray Diffraction | 1 | 2019 | 84 | 0.160 |
Why?
| | Body Weight | 5 | 2016 | 875 | 0.160 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2806 | 0.160 |
Why?
| | Polymers | 1 | 2022 | 448 | 0.160 |
Why?
| | Osteoarthritis, Knee | 1 | 2021 | 213 | 0.150 |
Why?
| | Knee Joint | 1 | 2021 | 324 | 0.150 |
Why?
| | Lipid Bilayers | 1 | 2019 | 99 | 0.150 |
Why?
| | Physical Exertion | 2 | 2012 | 211 | 0.150 |
Why?
| | Gene Expression | 4 | 2022 | 1424 | 0.150 |
Why?
| | Adrenal Glands | 1 | 2017 | 67 | 0.140 |
Why?
| | Rats | 5 | 2021 | 4980 | 0.140 |
Why?
| | Osteoprotegerin | 2 | 2015 | 23 | 0.140 |
Why?
| | Actins | 4 | 2020 | 383 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 949 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1203 | 0.130 |
Why?
| | Diffusion | 1 | 2016 | 118 | 0.130 |
Why?
| | Permeability | 1 | 2016 | 148 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2021 | 639 | 0.130 |
Why?
| | Energy Intake | 1 | 1999 | 420 | 0.130 |
Why?
| | Femoral Neck Fractures | 1 | 2016 | 22 | 0.130 |
Why?
| | Wound Healing | 1 | 2017 | 259 | 0.130 |
Why?
| | Kidney Function Tests | 1 | 2016 | 141 | 0.130 |
Why?
| | Weight-Bearing | 3 | 2021 | 166 | 0.130 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 35 | 0.130 |
Why?
| | Hemostatic Techniques | 1 | 2015 | 40 | 0.130 |
Why?
| | Environment | 2 | 2014 | 335 | 0.120 |
Why?
| | Tissue Preservation | 1 | 2014 | 13 | 0.120 |
Why?
| | Muscle Contraction | 2 | 2010 | 399 | 0.120 |
Why?
| | Phenotype | 2 | 2021 | 2814 | 0.120 |
Why?
| | Biocompatible Materials | 2 | 2016 | 369 | 0.120 |
Why?
| | Veins | 1 | 2014 | 57 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2014 | 91 | 0.110 |
Why?
| | Surface Properties | 3 | 2012 | 387 | 0.110 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 9 | 0.110 |
Why?
| | Tripartite Motif Proteins | 1 | 2013 | 30 | 0.110 |
Why?
| | Thermometry | 1 | 2013 | 1 | 0.110 |
Why?
| | Internet | 1 | 2018 | 601 | 0.110 |
Why?
| | Electrocoagulation | 1 | 2013 | 38 | 0.110 |
Why?
| | Neurogenesis | 1 | 2014 | 102 | 0.110 |
Why?
| | Proteomics | 1 | 2018 | 844 | 0.110 |
Why?
| | Vascular Surgical Procedures | 1 | 2015 | 261 | 0.110 |
Why?
| | Compliance | 1 | 2012 | 46 | 0.110 |
Why?
| | Eye | 1 | 2013 | 101 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 616 | 0.100 |
Why?
| | Tooth Calcification | 1 | 2012 | 3 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 324 | 0.100 |
Why?
| | Anthropology, Physical | 1 | 2012 | 28 | 0.100 |
Why?
| | Olfactory Bulb | 1 | 2014 | 123 | 0.100 |
Why?
| | Mitochondria | 2 | 2018 | 750 | 0.100 |
Why?
| | Madagascar | 1 | 2012 | 41 | 0.100 |
Why?
| | Molar | 1 | 2012 | 44 | 0.100 |
Why?
| | Catheter Ablation | 1 | 2015 | 291 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 139 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2013 | 3023 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2013 | 185 | 0.100 |
Why?
| | Reflex | 1 | 2012 | 65 | 0.100 |
Why?
| | Microscopy, Atomic Force | 1 | 2012 | 113 | 0.100 |
Why?
| | Cell Differentiation | 5 | 2020 | 1700 | 0.100 |
Why?
| | Hepatitis A | 4 | 1982 | 26 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2013 | 210 | 0.100 |
Why?
| | Placental Insufficiency | 1 | 2013 | 102 | 0.100 |
Why?
| | Viscoelastic Substances | 1 | 2011 | 9 | 0.100 |
Why?
| | Stress, Physiological | 2 | 2015 | 377 | 0.100 |
Why?
| | Ecology | 1 | 2012 | 97 | 0.100 |
Why?
| | Video Recording | 1 | 2012 | 145 | 0.100 |
Why?
| | Primates | 1 | 2012 | 111 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2013 | 482 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 20 | 0.090 |
Why?
| | Middle Aged | 6 | 2020 | 26872 | 0.090 |
Why?
| | Plastics | 1 | 2010 | 35 | 0.090 |
Why?
| | Reaction Time | 1 | 2012 | 374 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 827 | 0.090 |
Why?
| | Action Potentials | 1 | 2013 | 406 | 0.090 |
Why?
| | Electromagnetic Fields | 1 | 2010 | 22 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1231 | 0.090 |
Why?
| | Time Factors | 6 | 2013 | 6157 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 323 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2012 | 2192 | 0.090 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1524 | 0.090 |
Why?
| | Gestational Age | 1 | 2012 | 758 | 0.090 |
Why?
| | Skin | 1 | 2014 | 659 | 0.090 |
Why?
| | Myoglobin | 1 | 2009 | 14 | 0.080 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 131 | 0.080 |
Why?
| | Endothelial Cells | 2 | 2013 | 686 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 82 | 0.080 |
Why?
| | Granulocytes | 1 | 2008 | 78 | 0.080 |
Why?
| | Transcriptome | 3 | 2022 | 725 | 0.080 |
Why?
| | Fetus | 1 | 2013 | 702 | 0.080 |
Why?
| | Immunity | 1 | 2009 | 121 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2022 | 676 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6358 | 0.080 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1155 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2009 | 1042 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2098 | 0.080 |
Why?
| | Nanotechnology | 1 | 2009 | 113 | 0.070 |
Why?
| | Infant | 8 | 2017 | 7966 | 0.070 |
Why?
| | Sulfhydryl Compounds | 2 | 2022 | 177 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 267 | 0.070 |
Why?
| | Models, Animal | 2 | 2021 | 349 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2378 | 0.070 |
Why?
| | Regional Blood Flow | 1 | 2009 | 432 | 0.070 |
Why?
| | Metabolomics | 3 | 2017 | 527 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2388 | 0.070 |
Why?
| | Apoptosis | 1 | 2015 | 2368 | 0.070 |
Why?
| | Body Mass Index | 1 | 2013 | 1968 | 0.070 |
Why?
| | Muscular Disorders, Atrophic | 1 | 2005 | 3 | 0.060 |
Why?
| | Metabolome | 2 | 2018 | 285 | 0.060 |
Why?
| | Cell Survival | 3 | 2017 | 1022 | 0.060 |
Why?
| | Infant, Newborn | 5 | 2013 | 5052 | 0.060 |
Why?
| | Systems Integration | 1 | 2005 | 38 | 0.060 |
Why?
| | Men | 1 | 2005 | 19 | 0.060 |
Why?
| | Adult | 9 | 2013 | 30708 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1060 | 0.060 |
Why?
| | Sciatic Nerve | 1 | 2005 | 56 | 0.060 |
Why?
| | Hepatitis B | 4 | 1982 | 53 | 0.060 |
Why?
| | Pregnancy Complications | 1 | 2009 | 430 | 0.060 |
Why?
| | Cytokines | 2 | 2009 | 1843 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2010 | 850 | 0.060 |
Why?
| | Diaphyses | 1 | 2003 | 13 | 0.060 |
Why?
| | United States | 1 | 2020 | 12256 | 0.060 |
Why?
| | Adolescent | 9 | 2017 | 17887 | 0.060 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1036 | 0.050 |
Why?
| | Fascia | 1 | 2023 | 14 | 0.050 |
Why?
| | Ligaments | 1 | 2023 | 44 | 0.050 |
Why?
| | Lung | 1 | 2015 | 3595 | 0.050 |
Why?
| | Biomarkers | 4 | 2016 | 3421 | 0.050 |
Why?
| | Polystyrenes | 1 | 2022 | 36 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3250 | 0.050 |
Why?
| | Myocardium | 2 | 1997 | 925 | 0.050 |
Why?
| | Equipment Design | 2 | 2014 | 513 | 0.050 |
Why?
| | RNA, Messenger | 5 | 2016 | 2563 | 0.050 |
Why?
| | Genes, MHC Class II | 1 | 2002 | 70 | 0.050 |
Why?
| | Uterus | 1 | 2023 | 192 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2008 | 1748 | 0.050 |
Why?
| | Meniscus | 1 | 2021 | 21 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2021 | 79 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 254 | 0.050 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2020 | 5 | 0.040 |
Why?
| | Corticosterone | 2 | 2017 | 211 | 0.040 |
Why?
| | Biophysics | 1 | 2020 | 70 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 344 | 0.040 |
Why?
| | International Cooperation | 1 | 2001 | 172 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 189 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 369 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2000 | 45 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2001 | 339 | 0.040 |
Why?
| | Bone Substitutes | 1 | 1999 | 27 | 0.040 |
Why?
| | Durapatite | 1 | 1999 | 32 | 0.040 |
Why?
| | Osseointegration | 1 | 1999 | 37 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 225 | 0.040 |
Why?
| | Hydrostatic Pressure | 1 | 2019 | 19 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 113 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 333 | 0.040 |
Why?
| | Signal Transduction | 3 | 2018 | 4527 | 0.040 |
Why?
| | Lymphocyte Count | 2 | 2009 | 133 | 0.040 |
Why?
| | Humerus | 1 | 1998 | 40 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 107 | 0.040 |
Why?
| | Intracellular Space | 1 | 2018 | 68 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 193 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2001 | 253 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 157 | 0.040 |
Why?
| | Glycoproteins | 1 | 2000 | 305 | 0.040 |
Why?
| | Gray Matter | 1 | 2018 | 68 | 0.040 |
Why?
| | Cell Cycle | 1 | 2001 | 544 | 0.040 |
Why?
| | Femur Neck | 1 | 2018 | 59 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 10519 | 0.040 |
Why?
| | Dietary Fats | 1 | 2000 | 290 | 0.040 |
Why?
| | Receptors, Corticotropin | 1 | 2017 | 2 | 0.040 |
Why?
| | Glycolysis | 1 | 2018 | 227 | 0.040 |
Why?
| | Sarcomeres | 1 | 1997 | 90 | 0.040 |
Why?
| | Osteoporotic Fractures | 1 | 2018 | 56 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 746 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2002 | 970 | 0.040 |
Why?
| | White Matter | 1 | 2018 | 104 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2552 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2017 | 34 | 0.040 |
Why?
| | Polymerization | 1 | 2017 | 119 | 0.040 |
Why?
| | Catecholamines | 1 | 2017 | 97 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2018 | 212 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.030 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.030 |
Why?
| | PPAR alpha | 1 | 2016 | 52 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2017 | 98 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2020 | 775 | 0.030 |
Why?
| | Adhesiveness | 1 | 2015 | 19 | 0.030 |
Why?
| | Click Chemistry | 1 | 2016 | 48 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 277 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 56 | 0.030 |
Why?
| | RANK Ligand | 1 | 2015 | 26 | 0.030 |
Why?
| | Osteocalcin | 1 | 2015 | 34 | 0.030 |
Why?
| | Phagocytosis | 1 | 2017 | 352 | 0.030 |
Why?
| | Light | 1 | 2017 | 335 | 0.030 |
Why?
| | DNA Primers | 2 | 2010 | 515 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2008 | 1084 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2015 | 61 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2015 | 144 | 0.030 |
Why?
| | Surgical Equipment | 1 | 2014 | 13 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 536 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2109 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 168 | 0.030 |
Why?
| | Child, Preschool | 7 | 2017 | 9123 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2015 | 430 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2013 | 47 | 0.030 |
Why?
| | Shear Strength | 1 | 2013 | 65 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 2013 | 53 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 98 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2008 | 481 | 0.030 |
Why?
| | Hyalin | 1 | 2012 | 5 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1997 | 799 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2120 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2009 | 1860 | 0.030 |
Why?
| | Hepatitis, Viral, Human | 2 | 1982 | 25 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1317 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 9151 | 0.020 |
Why?
| | Stem Cells | 1 | 2015 | 547 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2010 | 58 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 926 | 0.020 |
Why?
| | Molecular Structure | 1 | 2011 | 438 | 0.020 |
Why?
| | Aged | 4 | 2003 | 19135 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2010 | 184 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 2 | 2001 | 49 | 0.020 |
Why?
| | Hemoglobin H | 1 | 1989 | 1 | 0.020 |
Why?
| | Antibodies, Viral | 3 | 1982 | 522 | 0.020 |
Why?
| | Thalassemia | 1 | 1989 | 7 | 0.020 |
Why?
| | Hemoglobins, Abnormal | 1 | 1989 | 10 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2008 | 45 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 58 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2008 | 79 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 57 | 0.020 |
Why?
| | Child | 7 | 2017 | 18466 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2008 | 91 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 292 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2525 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2008 | 164 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 304 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 574 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 928 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2008 | 276 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2008 | 128 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 323 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 499 | 0.020 |
Why?
| | Epidemiologic Methods | 3 | 1982 | 72 | 0.020 |
Why?
| | Microscopy, Fluorescence | 2 | 2001 | 398 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 202 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 310 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2008 | 138 | 0.020 |
Why?
| | Transfection | 2 | 2001 | 872 | 0.020 |
Why?
| | Hepatitis B Surface Antigens | 3 | 1982 | 19 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1540 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 812 | 0.020 |
Why?
| | Australia | 3 | 1982 | 206 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 2008 | 383 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 818 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 8658 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 827 | 0.020 |
Why?
| | Nerve Compression Syndromes | 1 | 2005 | 26 | 0.020 |
Why?
| | Pilot Projects | 1 | 2009 | 1377 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 2 | 2000 | 2216 | 0.010 |
Why?
| | Hepatovirus | 2 | 1982 | 3 | 0.010 |
Why?
| | Hepatitis B Core Antigens | 2 | 1981 | 5 | 0.010 |
Why?
| | Hepatitis B Antibodies | 2 | 1981 | 10 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 772 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1145 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 3897 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2645 | 0.010 |
Why?
| | Papua New Guinea | 1 | 1981 | 7 | 0.010 |
Why?
| | MyoD Protein | 1 | 2001 | 27 | 0.010 |
Why?
| | Altitude | 2 | 1981 | 435 | 0.010 |
Why?
| | Maxillofacial Prosthesis Implantation | 1 | 1999 | 3 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 198 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 139 | 0.010 |
Why?
| | Disease Outbreaks | 1 | 1982 | 309 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1980 | 176 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 59 | 0.010 |
Why?
| | Myosin Light Chains | 1 | 1997 | 26 | 0.010 |
Why?
| | Troponin | 1 | 1997 | 44 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 1997 | 140 | 0.010 |
Why?
| | Troponin T | 1 | 1997 | 49 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1997 | 173 | 0.010 |
Why?
| | Tropomyosin | 1 | 1997 | 12 | 0.010 |
Why?
| | Muscle Development | 1 | 1997 | 98 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 866 | 0.010 |
Why?
| | Molecular Weight | 1 | 1997 | 331 | 0.010 |
Why?
| | Age Factors | 2 | 1981 | 2900 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2002 | 2586 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1997 | 779 | 0.010 |
Why?
| | Heart | 1 | 1997 | 613 | 0.010 |
Why?
| | Prospective Studies | 2 | 1981 | 6245 | 0.010 |
Why?
| | Hepatitis C | 2 | 1982 | 228 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1982 | 163 | 0.000 |
Why?
| | New Guinea | 1 | 1981 | 4 | 0.000 |
Why?
| | Immunoglobulins | 1 | 1982 | 143 | 0.000 |
Why?
| | Injections | 1 | 1982 | 159 | 0.000 |
Why?
| | Family Health | 1 | 1982 | 194 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1982 | 252 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1982 | 4430 | 0.000 |
Why?
|
|
Ferguson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|